Nav: Home

Effect of decision aid in selecting antidepressant

September 28, 2015

Use of a decision aid helped primary care clinicians and patients with moderate to severe depression select antidepressants together but had no discernible effect on depression control and medication use and adherence, according to an article published online by JAMA Internal Medicine.

Depression is a common, debilitating, and costly chronic mental illness affecting an estimated 17 percent of Americans. Pharmacotherapy is a primary treatment, but the efficacy of antidepressants is reduced by low patient adherence rates and premature discontinuation. Annie LeBlanc, Ph.D., of the Mayo Clinic, Rochester, Minn., and colleagues studied the effect of the Depression Medication Choice (DMC) encounter decision aid on quality of the decision-making process and depression outcomes. This aid was designed to help patients and clinicians consider available antidepressants and the extent to which they improved depression and other issues important to patients.

Primary care practices in 10 rural, suburban, and urban primary care practices across Minnesota and Wisconsin were randomly allocated to treatment of depression with or without use of the DMC decision aid, which consisted of a series of cards, each highlighting the effect of the available options on an issue of importance to patients for use during face-to-face consultations.

The study included 117 clinicians and 301 patients with moderate to severe depression considering treatment with an antidepressant. Compared with usual care, use of DMC significantly improved patients' decisional comfort, knowledge, satisfaction, and involvement. It also improved clinicians' decisional comfort and satisfaction. There were no differences in encounter duration, medication adherence, or improvement of depression control between groups.

"Further work in this area is necessary. The ideal decision support should include nonpharmacological options. A larger and longer trial to study the effect of the decision aid on adherence to therapy in patients selected because of nonadherence may be more informative. Larger studies are needed to identify subgroups (i.e., socioeconomic status) that may benefit more from using the decision aid. Identifying the amount and type of support needed to effectively embed the use of this decision aid in the routines of primary care practices to support its longitudinal use also remains to be determined," the authors write.
(JAMA Intern Med. Published online September 28, 2015. doi:10.1001/jamainternmed.2015.5214. Available pre-embargo to the media at

Editor's Note: This study was funded by the Agency for Healthcare and Quality Research under the American Recovery and Reinvestment Act of 2009. No conflict of interest disclosures were reported.

Commentary: The Role of Decision Aids in Depression Care

"While better clinical outcomes are typically the bottom line for most interventions, certain patient-centered outcomes may have an independent intrinsic value," writes Kurt Kroenke, M.D., of the Regenstrief Institute Inc., Indianapolis, in a commentary.

"For example, 79 percent of the patients in the trial expressed a preference for either being the principal decision maker or sharing medical decisions with their clinician. One wonders how often in a busy clinical setting, when there is a choice among medications to treat a disease, the clinician actually discusses the pros and cons of different options. It may be less important for short-term use of drugs to treat acute conditions. However, for medications prescribed for chronic use, informed patient input may be especially desirable. Decision aids could either be used routinely or targeted toward certain patients based on their decision-making preference, sociodemographic characteristics, and history of medication intolerance or prior treatment failures."

(JAMA Intern Med. Published online September 28, 2015. doi:10.1001/jamainternmed.2015.5243. Available pre-embargo to the media at

Editor's Note: No conflict of interest disclosures were reported.

Media Advisory: To contact corresponding author Annie LeBlanc, Ph.D., call Robert Nellis at 507-284-5005 or email To contact commentary author Kurt Kroenke, M.D., call Cindy Fox Aisen at 317-413-7381 or email

To place an electronic embedded link in your story: Links will be live at the embargo time:

The JAMA Network Journals

Related Depression Articles:

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.
Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.
CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.
Post-natal depression in dads linked to depression in their teenage daughters
Fathers as well as mothers can experience post-natal depression -- and it is linked to emotional problems for their teenage daughters, new research has found.
Being overweight likely to cause depression, even without health complications
A largescale genomic analysis has found the strongest evidence yet that being overweight causes depression, even in the absence of other health problems.
More Depression News and Depression Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...